The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis

被引:47
作者
Downey, Damian G.
Martin, S. Lorraine
Dempster, Martin
Moore, John E.
Keogan, Mary T.
Starcher, Barry
Edgar, Julia
Bilton, Diana
Elborn, J. Stuart [1 ]
机构
[1] Belfast City Hosp, Adult Cyst Fibrosis Ctr, Belfast BT9 7AB, Antrim, North Ireland
[2] Queens Univ Belfast, Belfast, Antrim, North Ireland
[3] Papworth Hosp, Adult Cyst Fibrosis Ctr, Cambridge CB3 8RE, England
[4] Univ Texas, Tyler, TX USA
[5] PPL Therapeut Plc, Edinburgh, Midlothian, Scotland
关键词
cystic fibrosis; inflammation; survival; burkholderia cepacia;
D O I
10.1002/ppul.20553
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Decreased survival inpatients with cystic fibrosis has been related to FEV1, BMI, and infection with Burkholderia cepacia complex (BCC). We have assessed the relationship of blood, sputum, and urine inflammatory markers to lung function, BMI, colonization with B cenocepacia (Bc), and patient survival. Thirty-nine stable cystic fibrosis (CF) patients (10 with Bc) were enrolled in a study to determine the effect of alpha-1-antitrypsin on airways inflammation. Pre-treatment measurements were used in this study Demographics, sputum microbiology, heart rate, oxygen saturation, lung function were recorded. Blood samples were obtained for white blood count (WBC), C-Reactive Protein (CRP), and plasma neutrophil elastase/AAT complexes (pNEC). Neutrophil elastase (NE), neutrophil elastase/AAT complexes (sNEC), interleukin-8 (IL-8), TNF-receptor 1 (sTNFr), and myeloperoxidase (MPO) were measured in sputum and urinary desmosine concentration determined. Patients with Bc had significantly higher levels of pNEC, 332 +/- 91.4 ng/ml (mean +/- SEM) versus 106 +/- 18.2 ng/ml (P = 0.0005) and sNEC, 369 +/- 76.6 ng/ml versus 197 +/- 36.0 ng/ml compared to those who were not. Five deaths were reported at the end of 1 year, (four with Bc) (P = 0.011). Patients who subsequently died had significantly lower lung function FEV1, 1.2 +/- 0.2 L versus 2.0 +/- 0.1 L (P = 0.03) and FVC, 2 +/- 0.3 L versus 3.1 +/- 0.2 L (P = 0.01), compared to those that survived. There was significantly higher NE activity, 3.6 +/- 1.6 U/ml versus 1.5 +/- 0.6 U/ml (P = 0.03), pNEC, 274 +/- 99 ng/ml versus 142 +/- 30 ng/ml (P = 0.05), MPO, 163 +/- 62 mcg/ml versus 54 +/- 6.9 mcg/ml (P = 0.03), and urinary desmosines 108 +/- 19.9 pM/mg creatinine versus 51.1 +/- 3.3 pM/mg creatinine (P = 0.001), in those patients who subsequently died compared to those that survived. These data suggest there is increased neutrophil degranulation in patients infected with Bc and these patients have a poor outcome.
引用
收藏
页码:216 / 220
页数:5
相关论文
共 29 条
  • [1] BRUCE MC, 1985, AM REV RESPIR DIS, V132, P529
  • [2] COURTNEY JM, 2004, J CYST FIBROS, V2, P93
  • [3] Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients
    De Boeck, K
    Malfroot, A
    Van Schil, L
    Lebecque, P
    Knoop, C
    Govan, JRW
    Doherty, C
    Laevens, S
    Vandamme, P
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) : 851 - 856
  • [4] CYSTIC-FIBROSIS - CURRENT SURVIVAL AND POPULATION ESTIMATES TO THE YEAR 2000
    ELBORN, JS
    SHALE, DJ
    BRITTON, JR
    [J]. THORAX, 1991, 46 (12) : 881 - 885
  • [5] ELBORN JS, 1990, THORAX, V45, P97
  • [6] A prognostic model for the prediction of survival in cystic fibrosis
    Hayllar, KM
    Williams, SGJ
    Wise, AE
    Pouria, S
    Lombard, M
    Hodson, ME
    Westaby, D
    [J]. THORAX, 1997, 52 (04) : 313 - 317
  • [7] Cystic fibrosis:: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa
    Hendry, J
    Elborn, JS
    Nixon, L
    Shale, DJ
    Webb, AK
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (02) : 435 - 438
  • [8] JANOFF A, 1979, AM J PATHOL, V97, P111
  • [9] Burkholderia cenocepacia and Burkholderia multivorans:: influence on survival in cystic fibrosis
    Jones, AM
    Dodd, ME
    Govan, JRW
    Barcus, V
    Doherty, CJ
    Morris, J
    Webb, AK
    [J]. THORAX, 2004, 59 (11) : 948 - 951
  • [10] PREDICTION OF MORTALITY IN PATIENTS WITH CYSTIC-FIBROSIS
    KEREM, E
    REISMAN, J
    COREY, M
    CANNY, GJ
    LEVISON, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (18) : 1187 - 1191